Drug Trial Radar · NCT06204679
Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir
Last checked: Nov 20, 2026Latest source record: Sep 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
42
Actual
Start
Dec 14, 2023
Primary completion
Aug 25, 2024
Study completion Aug 25, 2024
Sponsor
- Lead sponsor
- Atea Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will assess comparative bioavailability and effect of food on a prototype fixed-dose combination (FDC) of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in healthy subjects
Conditions
- Healthy Volunteer Study
Interventions
Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditionsDrug
A Fixed-Dose Combination of Bemnifosbuvir (BEM) and Ruzasvir (RZR)
Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fed conditionsDrug
A Fixed-Dose Combination of Bemnifosbuvir (BEM) and Ruzasvir (RZR)
Bemnifosbuvir (BEM) and Ruzasvir (RZR) as reference formulation under fasting conditionsDrug
Bemnifosbuvir (BEM) and Ruzasvir (RZR) as separate formulations
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK) of FDC compared to reference:(Cmax)Time frame: Day 1, Day 7, Day 13
- Pharmacokinetics (PK) of FDC compared to reference:(AUC)Time frame: Day 1, Day 7, Day 13
- Food effect of Fixed Dose Combination of Bemnifosbuvir (BEM)/Ruzasvir (RZR):(Cmax)Time frame: Day 1, Day 7, Day 13
- Food effect of Fixed Dose Combination of Bemnifosbuvir (BEM)/Ruzasvir (RZR):(AUC)Time frame: Day 1, Day 7, Day 13
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Atea Study Site
Cypress, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.